| This study reviewed the medical records of women receiving denosumab for the treatment of postmenopausal osteoporosis in Bulgaria. |
| The characteristics of the women suggest that they were at high risk of fracture before they were prescribed denosumab. |
| Denosumab increased bone mineral density after 1 year of treatment, which may help to reduce the risk of fractures in this patient population. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.